Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
[Decrease of cardiac potential in homogenous cylindrical system; comparison with a dipole center].

Archives internationales de physiologie et de biochimie

VANREMOORTERE E.
PMID: 13395638
Arch Int Physiol Biochim. 1956 Nov;64(4):684-7. doi: 10.3109/13813455609145443.

No abstract available.

Cite
VANREMOORTERE E. Décroissance des potentiels cardiaques dans un milieu cylindrique homogène; comparaison avec un dipôle centré. [Decrease of cardiac potential in homogenous cylindrical system; comparison with a dipole center]. Arch Int Physiol Biochim. 1956;64(4):684-7doi: 10.3109/13813455609145443.
VANREMOORTERE, E. (1956). Décroissance des potentiels cardiaques dans un milieu cylindrique homogène; comparaison avec un dipôle centré. [Decrease of cardiac potential in homogenous cylindrical system; comparison with a dipole center]. Archives internationales de physiologie et de biochimie, 64(4), 684-7. https://doi.org/10.3109/13813455609145443
VANREMOORTERE, E. "Décroissance des potentiels cardiaques dans un milieu cylindrique homogène; comparaison avec un dipôle centré." [Decrease of cardiac potential in homogenous cylindrical system; comparison with a dipole center]. Archives internationales de physiologie et de biochimie vol. 64,4 (1956): 684-7. doi: https://doi.org/10.3109/13813455609145443
VANREMOORTERE E. Décroissance des potentiels cardiaques dans un milieu cylindrique homogène; comparaison avec un dipôle centré. [Decrease of cardiac potential in homogenous cylindrical system; comparison with a dipole center]. Arch Int Physiol Biochim. 1956 Nov;64(4):684-7. doi: 10.3109/13813455609145443. French. PMID: 13395638.
Copy Download .nbib Format: NLM
Relation between Heart Rate Variability and Disease Course in Multiple Sclerosis.

Journal of clinical medicine

Reynders T, Gidron Y, De Ville J, Bjerke M, Weets I, Van Remoortel A, Devolder L, D'haeseleer M, De Keyser J, Nagels G, D'hooghe MB.
PMID: 31861312
J Clin Med. 2019 Dec 18;9(1). doi: 10.3390/jcm9010003.

Little is known about the interplay between the autonomic nervous system and disease activity in multiple sclerosis (MS). We examined the relationship between heart rate variability (HRV), a reliable measure of vagal nerve function, and disease characteristics in a...

Cite
Reynders T, Gidron Y, De Ville J, et al. Relation between Heart Rate Variability and Disease Course in Multiple Sclerosis. J Clin Med. 2019;9(1)doi: 10.3390/jcm9010003.
Reynders, T., Gidron, Y., De Ville, J., Bjerke, M., Weets, I., Van Remoortel, A., Devolder, L., D'haeseleer, M., De Keyser, J., Nagels, G., & D'hooghe, M. B. (2019). Relation between Heart Rate Variability and Disease Course in Multiple Sclerosis. Journal of clinical medicine, 9(1), . https://doi.org/10.3390/jcm9010003
Reynders, Tatjana, et al. "Relation between Heart Rate Variability and Disease Course in Multiple Sclerosis." Journal of clinical medicine vol. 9,1 (2019). doi: https://doi.org/10.3390/jcm9010003
Reynders T, Gidron Y, De Ville J, Bjerke M, Weets I, Van Remoortel A, Devolder L, D'haeseleer M, De Keyser J, Nagels G, D'hooghe MB. Relation between Heart Rate Variability and Disease Course in Multiple Sclerosis. J Clin Med. 2019 Dec 18;9(1). doi: 10.3390/jcm9010003. PMID: 31861312; PMCID: PMC7019937.
Copy Download .nbib Format: NLM
Correlations of health status indicators with perceived neuropsychological impairment and cognitive processing speed in multiple sclerosis.

Multiple sclerosis and related disorders

D'hooghe MB, De Cock A, Van Remoortel A, Benedict RHB, Eelen P, Peeters E, D'haeseleer M, De Keyser J, Nagels G.
PMID: 31981931
Mult Scler Relat Disord. 2019 Dec 20;39:101904. doi: 10.1016/j.msard.2019.101904. Epub 2019 Dec 20.

BACKGROUND: Comorbidity and health behaviours may explain heterogeneity regarding cognitive performance in multiple sclerosis. Patient-reported cognitive difficulties have impact but do not consistently correlate with objective cognitive performance. Our study aims to investigate whether health status indicators including comorbidities,...

Cite
D'hooghe MB, De Cock A, Van Remoortel A, et al. Correlations of health status indicators with perceived neuropsychological impairment and cognitive processing speed in multiple sclerosis. Mult Scler Relat Disord. 2019;39:101904doi: 10.1016/j.msard.2019.101904.
D'hooghe, M. B., De Cock, A., Van Remoortel, A., Benedict, R. H. B., Eelen, P., Peeters, E., D'haeseleer, M., De Keyser, J., & Nagels, G. (2019). Correlations of health status indicators with perceived neuropsychological impairment and cognitive processing speed in multiple sclerosis. Multiple sclerosis and related disorders, 39101904. https://doi.org/10.1016/j.msard.2019.101904
D'hooghe, Marie B, et al. "Correlations of health status indicators with perceived neuropsychological impairment and cognitive processing speed in multiple sclerosis." Multiple sclerosis and related disorders vol. 39 (2019): 101904. doi: https://doi.org/10.1016/j.msard.2019.101904
D'hooghe MB, De Cock A, Van Remoortel A, Benedict RHB, Eelen P, Peeters E, D'haeseleer M, De Keyser J, Nagels G. Correlations of health status indicators with perceived neuropsychological impairment and cognitive processing speed in multiple sclerosis. Mult Scler Relat Disord. 2019 Dec 20;39:101904. doi: 10.1016/j.msard.2019.101904. Epub 2019 Dec 20. PMID: 31981931.
Copy Download .nbib Format: NLM
The Impact of Cognitive Dysfunction on Locomotor Rehabilitation Potential in Multiple Sclerosis.

Journal of central nervous system disease

Denissen S, De Cock A, Meurrens T, Vleugels L, Van Remoortel A, Gebara B, D'Haeseleer M, D'Hooghe MB, Van Schependom J, Nagels G.
PMID: 31723322
J Cent Nerv Syst Dis. 2019 Nov 06;11:1179573519884041. doi: 10.1177/1179573519884041. eCollection 2019.

BACKGROUND: Cognitive dysfunction is a frequent manifestation of multiple sclerosis (MS) but its effect on locomotor rehabilitation is unknown.OBJECTIVE: To study the impact of cognitive impairment on locomotor rehabilitation outcome in people with MS.METHODS: We performed a retrospective analysis...

Cite
Denissen S, De Cock A, Meurrens T, et al. The Impact of Cognitive Dysfunction on Locomotor Rehabilitation Potential in Multiple Sclerosis. J Cent Nerv Syst Dis. 2019;11:1179573519884041doi: 10.1177/1179573519884041.
Denissen, S., De Cock, A., Meurrens, T., Vleugels, L., Van Remoortel, A., Gebara, B., D'Haeseleer, M., D'Hooghe, M. B., Van Schependom, J., & Nagels, G. (2019). The Impact of Cognitive Dysfunction on Locomotor Rehabilitation Potential in Multiple Sclerosis. Journal of central nervous system disease, 111179573519884041. https://doi.org/10.1177/1179573519884041
Denissen, Stijn, et al. "The Impact of Cognitive Dysfunction on Locomotor Rehabilitation Potential in Multiple Sclerosis." Journal of central nervous system disease vol. 11 (2019): 1179573519884041. doi: https://doi.org/10.1177/1179573519884041
Denissen S, De Cock A, Meurrens T, Vleugels L, Van Remoortel A, Gebara B, D'Haeseleer M, D'Hooghe MB, Van Schependom J, Nagels G. The Impact of Cognitive Dysfunction on Locomotor Rehabilitation Potential in Multiple Sclerosis. J Cent Nerv Syst Dis. 2019 Nov 06;11:1179573519884041. doi: 10.1177/1179573519884041. eCollection 2019. PMID: 31723322; PMCID: PMC6836301.
Copy Download .nbib Format: NLM
Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection.

The Journal of antimicrobial chemotherapy

Gane EJ, Schwabe C, Berliba E, Tangkijvanich P, Jucov A, Ghicavii N, Verbinnen T, Lenz O, Talloen W, Kakuda TN, Westland C, Patel M, Yogaratnam JZ, Dragone L, Van Remoortere P.
PMID: 35040959
J Antimicrob Chemother. 2022 Jan 18; doi: 10.1093/jac/dkab491. Epub 2022 Jan 18.

OBJECTIVES: We investigated JNJ-64530440 (a hepatitis B virus capsid assembly modulator) safety, antiviral activity and pharmacokinetics in patients with chronic hepatitis B (CHB) (Phase 1b, NCT03439488).METHODS: Twenty treatment-naive, HBeAg-positive or -negative CHB patients were randomized 4‍:‍1 to JNJ-64530440 750...

Cite
Gane EJ, Schwabe C, Berliba E, et al. Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection. J Antimicrob Chemother. 2022;doi: 10.1093/jac/dkab491.
Gane, E. J., Schwabe, C., Berliba, E., Tangkijvanich, P., Jucov, A., Ghicavii, N., Verbinnen, T., Lenz, O., Talloen, W., Kakuda, T. N., Westland, C., Patel, M., Yogaratnam, J. Z., Dragone, L., & Van Remoortere, P. (2022). Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection. The Journal of antimicrobial chemotherapy, . https://doi.org/10.1093/jac/dkab491
Gane, Ed J, et al. "Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection." The Journal of antimicrobial chemotherapy vol. (2022). doi: https://doi.org/10.1093/jac/dkab491
Gane EJ, Schwabe C, Berliba E, Tangkijvanich P, Jucov A, Ghicavii N, Verbinnen T, Lenz O, Talloen W, Kakuda TN, Westland C, Patel M, Yogaratnam JZ, Dragone L, Van Remoortere P. Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection. J Antimicrob Chemother. 2022 Jan 18; doi: 10.1093/jac/dkab491. Epub 2022 Jan 18. PMID: 35040959.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries